Hyperbaric oxygen therapy (HBOT) is a physician-supervised treatment in which patients breathe 100% medical-grade oxygen at increased atmospheric pressure to support repair of injured tissue, reduce neuroinflammation, and restore cerebral blood flow. For adults recovering from mild traumatic brain injury (mTBI), what most people call a concussion, standard protocols consist of rest, graduated return to activity, and time. For a portion of patients, those measures are sufficient. For another portion, symptoms persist well past the expected recovery window: headaches that do not resolve, cognitive fog that interferes with work, sleep that no longer refreshes, and light or sound sensitivity that restricts daily life. This presentation is called post-concussion syndrome (PCS), and HBOT is one of the more rigorously studied adjunct interventions for its care.
TrufaMED offers physician-supervised hyperbaric oxygen therapy at our Surfside clinic at 9445 Harding Ave, Surfside, FL 33154, with evaluation and protocol design led by board-certified physicians. TrufaMED is the only Joint Commission-accredited urgent care facility in Florida, applying the same standard of physician oversight to hyperbaric treatment that we apply across all clinical services.
What Happens to the Brain After a Concussion
Concussion is a biomechanical event. The brain accelerates or decelerates rapidly inside the skull, shearing axons, disrupting ion channels, and triggering a metabolic crisis at the cellular level. The Glasgow Coma Scale typically reads normal (13 to 15), standard CT and MRI imaging is usually negative, and the injury is therefore classified as mild. That classification refers to a standardized severity scale, not to the functional impact, which for a significant portion of patients is substantial and prolonged.
The cascade that follows the initial mechanical event includes several simultaneous processes:
- Excitotoxicity from sudden glutamate release at injured synapses
- Mitochondrial dysfunction that reduces ATP production in neurons operating under increased metabolic demand
- Microvascular disruption that limits oxygen delivery to damaged tissue
- Neuroinflammation driven by activated microglia and reactive astrocytes in the injury zone
The result is a metabolic mismatch: an injured brain with increased energy demands and reduced oxygen supply. This mismatch is the biological target that hyperbaric oxygen therapy is designed to address. Understanding the mechanism of injury is the starting point for understanding why HBOT is a clinically reasoned intervention rather than a general wellness treatment.
How HBOT Addresses the Biology of mTBI
Inside a hyperbaric chamber, atmospheric pressure is raised to 1.5 to 2.0 ATA while the patient breathes 100% oxygen. At that pressure, oxygen dissolves directly into the plasma rather than relying solely on hemoglobin transport. Plasma-dissolved oxygen reaches areas where red blood cells cannot easily circulate: compressed microvasculature, edematous tissue, and zones of ischemia surrounding the injury site.
Reduction of Neuroinflammation
HBOT down-regulates pro-inflammatory cytokines and supports resolution of microglial activation, the primary cellular driver of ongoing tissue damage after the initial mechanical event. Chronic microglial activation in post-concussion syndrome is measurable on PET imaging and correlates with symptom burden. Repeated hyperbaric sessions shift the inflammatory milieu toward resolution rather than persistence.
Mitochondrial Function Restoration
Increased oxygen tension restores ATP production in neurons operating in an energy-deficient state. This correction of the metabolic deficit is consistent with observed improvements in cognitive speed, attention, and fatigue that patients and researchers report across HBOT protocols for PCS. The neurons are not dead; they are metabolically impaired, and oxygen availability is the rate-limiting variable.
Angiogenesis in Hypoperfused Regions
Repeated cycles of hyperoxygenation followed by return to normobaric conditions trigger vascular endothelial growth factor (VEGF) release, stimulating growth of new capillaries in regions with chronic hypoperfusion. This angiogenic response is one mechanism by which HBOT produces durable improvement rather than transient symptom relief, and it corresponds to the perfusion changes observed on SPECT imaging in published trials.
Neuroprotection of Peri-Injury Tissue
Preclinical and clinical data indicate HBOT supports axonal integrity and reduces apoptosis in the tissue surrounding the primary injury site. The cells at the injury margin are at risk but not yet lost. Providing adequate oxygen during the period of metabolic vulnerability preserves a larger volume of functional tissue than rest alone.
What the Published Research Shows
Several controlled studies have examined HBOT specifically for chronic PCS, with consistent findings across different patient populations and injury mechanisms.
Tal et al. (2015, Neurological Sciences): A randomized controlled trial of 56 patients with persistent post-concussion syndrome found statistically significant improvements in cognitive function, quality of life, and symptom burden in the HBOT group treated at 1.5 ATA for 40 sessions, compared to sham controls. SPECT imaging showed increased cerebral blood flow in HBOT-treated subjects at end of protocol, providing objective neuroimaging correlates to the clinical findings.
Harch et al. (2012, PLoS ONE): A prospective study of 16 patients with chronic blast-induced mTBI and PCS showed improvement in cognitive testing, sleep, headache severity, and post-traumatic stress symptom scores after 40 HBOT sessions. Neuroimaging demonstrated perfusion changes in multiple brain regions that corresponded to areas of prior symptom generation.
Wolf et al. (2012, Military Medicine): A retrospective analysis of 50 military service members with blast-induced concussion showed improved cognitive and behavioral outcomes with HBOT, with a dose-response relationship suggesting that session count matters and that the full 40-session protocol produces greater benefit than abbreviated courses.
These trials involve modest sample sizes and heterogeneous populations. They are not definitive proof of population-level efficacy. They do provide a plausible mechanistic and clinical basis for offering HBOT as part of a supervised recovery plan for appropriate patients. TrufaMED does not represent that HBOT cures concussion or guarantees symptom resolution. The published evidence supports its use as a structured adjunct intervention in patients with chronic PCS who have not responded adequately to standard management alone.
Who Is a Candidate for HBOT After Concussion
Candidacy for HBOT is determined by physician evaluation at TrufaMED, not by a self-reported symptom checklist. The populations in whom HBOT has the strongest evidence base and clinical rationale include:
Contact sport athletes with repetitive impacts: Athletes who play football, box, wrestle, compete in rugby, or participate in ice hockey frequently accumulate multiple concussions over a career, whether or not each individual event met clinical concussion criteria at the time of the hit. Repetitive sub-threshold impacts are associated with cumulative axonal disruption and a pattern of neuroinflammatory burden that HBOT protocols directly target. This is the athlete population for whom early evaluation and intervention carry the most practical value.
Adults with PCS persisting beyond four to six weeks: When standard post-concussion management, consisting of graduated return to activity, sleep hygiene measures, and cognitive workload reduction, has not produced expected symptom resolution at four to six weeks, further evaluation is warranted. Persistent symptom burden at that interval is a recognized clinical indicator for considering adjunct interventions. Waiting beyond three months without additional assessment prolongs avoidable impairment.
Patients with documented cerebral hypoperfusion: SPECT or functional MRI findings showing regional hypoperfusion in the setting of chronic PCS are among the strongest predictors of HBOT response in the published data. If imaging has been performed and shows hypoperfused regions, that finding directly informs protocol design and expected response.
Military personnel and veterans with blast-induced TBI: Blast concussions from explosive pressure waves involve a distinct injury mechanism compared to sports or motor vehicle concussions, and they tend to produce more refractory PCS. HBOT has its largest controlled-trial evidence base in this population, and the Department of Defense has funded multiple investigations into its use for service-related brain injury.
Patients with untreated sinus or ear pathology, active respiratory infection, specific pulmonary conditions, or severe claustrophobia require additional evaluation before HBOT. These contraindications are assessed as part of the physician intake at TrufaMED.
What a Post-Concussion HBOT Protocol Looks Like at TrufaMED
TrufaMED’s hyperbaric program includes physician evaluation, individualized protocol design, and monitoring across the full course of treatment, not only at the initial visit.
Session parameters: Published protocols for mTBI use 1.5 to 2.0 ATA with 100% oxygen, sessions of 60 to 90 minutes each, delivered five days per week. The 40-session course used in trials that showed measurable cognitive and symptomatic improvement is the clinical benchmark. Patients with more chronic presentations or longer symptom duration receive additional sessions based on physician assessment of mid-protocol response and trajectory.
Individualized protocol design: There is no universal post-concussion HBOT protocol because the clinical picture varies substantially between patients. A patient six weeks out from a first sports concussion differs from a patient two years out with neuropsychological testing showing measurable cognitive decline and documented hypoperfusion on SPECT. The physician evaluation identifies presenting symptoms, prior concussion history, previous treatment response, and available imaging findings, then determines the appropriate starting parameters.
Physician-led oversight throughout: Dr. Uri Gedalia, CMO and Board-Certified General Surgeon, and Dr. Shane D. Naidoo, Medical Director and Board-Certified Emergency Medicine physician, direct TrufaMED’s clinical programs. Our medical staff page provides full credential details. HBOT for neurological indications requires the same physician-led oversight as any other medical treatment: intake evaluation, symptom monitoring, and protocol adjustment based on clinical response.
Monitoring across the full protocol: Symptom tracking at defined intervals across the protocol allows the physician team to assess trajectory and adjust parameters if needed. Some patients experience a transient increase in headache intensity during the first five to ten sessions, which typically resolves without protocol interruption. Monitoring is what distinguishes a medically supervised course from an unsupervised one.
For current session rates and package pricing, see our HBOT pricing page. For insurance coverage questions, review our insurance page. Medicare and most commercial plans do not currently cover HBOT for mTBI or PCS; HSA and FSA documentation is available upon request.
Integrating HBOT into a Complete Recovery Plan
HBOT addresses specific biological mechanisms that perpetuate post-concussion symptoms. It functions as a complement to the other components of a well-designed recovery plan, not as a replacement for them. For patients with chronic PCS, TrufaMED physicians consider how HBOT integrates with the patient’s existing management:
- Vestibular rehabilitation: Vestibular dysfunction is present in a significant proportion of concussion patients and requires dedicated physical therapy distinct from general aerobic reconditioning. HBOT and vestibular rehab address different aspects of the injury and can proceed concurrently.
- Cognitive load management: Graduated return to screen time, reading, and sustained mental effort, calibrated to individual tolerance and adjusted by symptom response rather than a fixed calendar, reduces the cognitive stress that delays recovery.
- Sleep intervention: Sleep architecture disruption is both a symptom of PCS and a driver of slow recovery trajectory. Addressing it specifically, with targeted behavioral intervention or sleep-focused medical evaluation, accelerates overall response.
- Structured aerobic conditioning: The Buffalo Concussion Treadmill Test protocol establishes a safe exertion threshold for individual patients. Aerobic exercise within that threshold is among the most evidence-supported interventions in PCS management and can proceed alongside HBOT without interference.
TrufaMED physicians coordinate the HBOT protocol with neurologists, neuropsychologists, vestibular physical therapists, and other providers involved in the patient’s care. Our concierge medicine program provides enhanced physician access for patients managing a complex, multi-provider recovery across specialties.
Questions and Answers
How many HBOT sessions are needed for post-concussion recovery?
Published protocols that produced measurable cognitive and symptomatic benefit used 40 sessions as the standard course, delivered five days per week over eight weeks. Some patients with more chronic or severe presentations complete additional sessions based on mid-protocol physician assessment. Fewer than 20 sessions is unlikely to produce the neuroregenerative effects observed in controlled trials, and abbreviated courses are not supported by the published evidence base.
Is HBOT covered by insurance for concussion?
Medicare and most commercial insurers cover HBOT for a specific list of statutory indications that does not currently include mTBI or post-concussion syndrome. Patients pursuing HBOT for concussion recovery typically do so as an out-of-pocket expense. TrufaMED provides itemized documentation that can be submitted to HSA or FSA accounts. Review the insurance page for the full list of covered indications and accepted health plans.
What chamber pressure is used for post-concussion HBOT?
Clinical trials for mTBI have used 1.5 to 2.0 ATA. The Tal et al. randomized trial used 1.5 ATA; the Harch blast-injury protocol also used 1.5 ATA. Pressures above 2.0 ATA are standard for wound healing and decompression illness but are not the protocol for neurological indications. At TrufaMED, chamber pressure is determined by the physician evaluation based on individual presentation, not by a fixed formula applied uniformly.
Can HBOT address cognitive symptoms specifically?
Cognitive symptoms, including difficulty concentrating, word retrieval problems, and slowed processing speed, are primary outcomes measured in PCS HBOT trials. The Tal et al. trial showed statistically significant improvement in cognitive function scores in the HBOT group relative to sham controls. The mechanism, restoration of metabolic function in neurons with impaired mitochondrial output and reduced oxygen availability, is consistent with the observed cognitive improvements. Response is variable between patients; physician monitoring determines whether cognitive trajectory is improving on protocol and whether parameters warrant adjustment.
Is HBOT safe for someone recovering from a concussion?
For appropriate candidates without contraindications, HBOT at 1.5 to 2.0 ATA has a documented safety profile across multiple clinical populations. The most common adverse effect is middle ear barotrauma from pressure equalization difficulty, managed with preparation techniques and, in some cases, tympanostomy tubes. Oxygen toxicity seizures are rare at the pressures used for neurological protocols, with an incidence below 1 in 10,000 sessions in clinical settings. Contraindication assessment at the physician evaluation identifies patients for whom the risk profile requires additional precaution or modification.
How soon after a concussion can HBOT begin?
Published studies enrolled patients with chronic PCS, defined as symptoms persisting beyond three months. The strongest clinical rationale for HBOT is in patients with documented persistent impairment, not in the acute phase when rest and graduated return to activity are the standard of care and most patients recover without additional intervention. For patients whose symptoms persist at four to six weeks without expected improvement, a physician evaluation to assess candidacy for adjunct interventions including HBOT is appropriate at that point rather than waiting for the three-month chronic threshold.
Does TrufaMED see patients from outside Miami Beach?
TrufaMED’s hyperbaric facility at 9445 Harding Ave, Surfside, FL 33154 is accessible from Miami Beach, Bal Harbour, Aventura, Brickell, Coral Gables, and the broader Miami-Dade area. Given the five-day-per-week frequency of standard HBOT protocols, patients traveling from outside Miami-Dade often arrange accommodations in Surfside or Miami Beach for the protocol duration. The clinical team provides a written protocol summary to coordinate with referring physicians and other specialists already involved in the patient’s care.
To schedule a physician evaluation and determine whether HBOT is appropriate for your post-concussion recovery, contact TrufaMED at (305) 537-6396. The clinic is located at 9445 Harding Ave, Surfside, FL 33154. Hours are Monday through Friday, 9 AM to 9 PM; Saturday, 11 AM to 11 PM; and Sunday, 12 PM to 8 PM. The evaluation is the clinical starting point. All treatment decisions are made by board-certified physicians with your specific history, symptom profile, and imaging in front of them.